Samata Leather Complex Ltd. (DSE:SAMATALETH)

G1 Therapeutics Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	55.97	43.17	50.52	58.41	75.56
Revenue Growth (YoY)	29.64%	-14.55%	-13.50%	-22.69%	-16.57%
Cost of Revenue	50.44	37.46	46.51	52.46	67.85
Gross Profit	5.53	5.72	4.02	5.95	7.71
Selling, General & Admin	4.62	3.25	4.7	4.57	5.17
Other Operating Expenses	0.39	0.14	0.19	0.06	0.14
Operating Expenses	5.01	3.38	4.89	4.63	5.3
Operating Income	0.52	2.33	-0.87	1.32	2.4
Interest & Investment Income	-	-	-	0	0
Currency Exchange Gain (Loss)	-0.05	-	-	-	-
Other Non Operating Income (Expenses)	0.8	-1.17	1.47	0.22	0.19
EBT Excluding Unusual Items	1.27	1.16	0.6	1.54	2.59
Gain (Loss) on Sale of Assets	-	-	-	-	0.04
Pretax Income	1.27	1.16	0.6	1.54	2.64
Income Tax Expense	0.74	0.76	1.27	0.46	1.66
Net Income	0.54	0.4	-0.67	1.08	0.98
Net Income to Common	0.54	0.4	-0.67	1.08	0.98
Net Income Growth	33.93%	-	-	10.55%	-66.26%
Shares Outstanding (Basic)	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10
EPS (Basic)	0.05	0.04	-0.06	0.10	0.09
EPS (Diluted)	0.05	0.04	-0.06	0.10	0.09
EPS Growth	33.93%	-	-	10.55%	-66.26%
Free Cash Flow	-0.56	-0.73	0.82	1.16	1.88
Free Cash Flow Per Share	-0.05	-0.07	0.08	0.11	0.18
Dividend Per Share	0.040	0.040	-	0.050	-
Gross Margin	9.87%	13.24%	7.95%	10.19%	10.20%
Operating Margin	0.92%	5.40%	-1.73%	2.26%	3.18%
Profit Margin	0.96%	0.93%	-1.32%	1.85%	1.29%
Free Cash Flow Margin	-1.00%	-1.69%	1.63%	1.98%	2.49%
EBITDA	-	-	-	5.08	6.16
EBITDA Margin	-	-	-	8.70%	8.15%
D&A For EBITDA	-	-	-	3.76	3.76
EBIT	0.52	2.33	-0.87	1.32	2.4
EBIT Margin	0.92%	5.40%	-1.73%	2.26%	3.18%
Effective Tax Rate	57.86%	65.61%	211.80%	29.89%	62.90%
Advertising Expenses	-	-	-	0.08	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.